Northwestern Mutual Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.4M Sell
119,596
-54,812
-31% -$2.6M ﹤0.01% 847
2025
Q4
$8.87M Sell
174,408
-14,738
-8% -$754K 0.01% 606
2025
Q3
$10.5M Buy
189,146
+3,004
+2% +$176K 0.01% 529
2025
Q2
$12.8M Sell
186,142
-217,249
-54% -$14.8M 0.01% 470
2025
Q1
$28M Buy
403,391
+26,935
+7% +$2.22M 0.02% 306
2024
Q4
$32.4M Sell
376,456
-61,777
-14% -$6.68M 0.03% 268
2024
Q3
$52.2M Sell
438,233
-10,277
-2% -$1.37M 0.05% 196
2024
Q2
$64M Buy
448,510
+24,646
+6% +$3.27M 0.06% 145
2024
Q1
$54.4M Buy
423,864
+91,989
+28% +$11M 0.06% 167
2023
Q4
$34.3M Buy
331,875
+143,908
+77% +$14.2M 0.04% 229
2023
Q3
$17.1M Buy
187,967
+94,759
+102% +$8.35M 0.02% 291
2023
Q2
$7.54M Buy
93,208
+8,010
+9% +$654K 0.01% 422
2023
Q1
$6.78M Buy
85,198
+9,320
+12% +$661K 0.01% 424
2022
Q4
$5.13M Buy
75,878
+2,678
+4% +$157K 0.01% 465
2022
Q3
$3.65M Sell
73,200
-4,248
-5% -$228K 0.01% 493
2022
Q2
$4.32M Buy
77,448
+4,524
+6% +$251K 0.01% 459
2022
Q1
$4.05M Sell
72,924
-1,988
-3% -$102K 0.01% 486
2021
Q4
$4.2M Buy
74,912
+7,894
+12% +$428K 0.01% 444
2021
Q3
$3.22M Buy
67,018
+326
+0.5% +$15.8K 0.01% 466
2021
Q2
$2.79M Buy
66,692
+11,448
+21% +$444K 0.01% 482
2021
Q1
$1.86M Buy
55,244
+36
+0.1% +$1.28K ﹤0.01% 535
2020
Q4
$1.93M Buy
55,208
+3,630
+7% +$125K ﹤0.01% 482
2020
Q3
$1.79M Sell
51,578
-414
-0.8% -$13.8K ﹤0.01% 445
2020
Q2
$1.7M Sell
51,992
-2,826
-5% -$90.2K 0.01% 430
2020
Q1
$1.65M Sell
54,818
-3,786
-6% -$113K 0.01% 388
2019
Q4
$1.7M Buy
58,604
+5,452
+10% +$151K 0.01% 423
2019
Q3
$1.37M Buy
53,152
+4,886
+10% +$124K 0.01% 438
2019
Q2
$1.23M Buy
48,266
+2,198
+5% +$54.3K 0.01% 440
2019
Q1
$1.21M Sell
46,068
-490
-1% -$12K 0.01% 429
2018
Q4
$1.07M Sell
46,558
-284
-0.6% -$6.31K 0.01% 428
2018
Q3
$1.1M Buy
46,842
+7,320
+19% +$179K 0.01% 411
2018
Q2
$911K Buy
39,522
+776
+2% +$18.4K 0.01% 434
2018
Q1
$954K Sell
38,746
-5,544
-13% -$146K 0.01% 410
2017
Q4
$1.19M Sell
44,290
-4,222
-9% -$107K 0.01% 347
2017
Q3
$1.17M Buy
48,512
+4,890
+11% +$111K 0.01% 327
2017
Q2
$935K Sell
43,622
-2,446
-5% -$49.4K 0.01% 358
2017
Q1
$790K Sell
46,068
-18,980
-29% -$330K 0.01% 371
2016
Q4
$1.17M Buy
+65,048
New +$1.18M 0.01% 315
2016
Q3
Sell
-93,662
Closed -$2.52M 1077
2016
Q2
$2.52M Sell
93,662
-8,766
-9% -$240K 0.04% 212
2016
Q1
$2.78M Buy
102,428
+14,316
+16% +$384K 0.05% 193
2015
Q4
$2.56M Buy
88,112
+1,326
+2% +$36.7K 0.05% 192
2015
Q3
$2.35M Sell
86,786
-3,378
-4% -$95.6K 0.06% 194
2015
Q2
$2.47M Sell
90,164
-5,538
-6% -$156K 0.06% 180
2015
Q1
$2.56M Buy
95,702
+18,716
+24% +$431K 0.07% 172
2014
Q4
$1.63M Buy
76,986
+9,698
+14% +$217K 0.05% 202
2014
Q3
$1.6M Buy
67,288
+7,748
+13% +$178K 0.06% 194
2014
Q2
$1.38M Buy
59,540
+2,654
+5% +$58.6K 0.05% 193
2014
Q1
$1.3M Buy
56,886
+12,636
+29% +$269K 0.05% 193
2013
Q4
$818K Buy
44,250
+10,140
+30% +$177K 0.04% 221
2013
Q3
$578K Buy
34,110
+11,710
+52% +$197K 0.03% 244
2013
Q2
$348K Buy
+22,400
New +$373K 0.02% 283

Other funds holding NVO

Northwestern Mutual Wealth Management's NVO Position: Q1 2026 in Review

Northwestern Mutual Wealth Management reduced its Novo Nordisk (NVO) stake by 31% in Q1 2026, selling an estimated $2.6M and leaving 119,596 shares worth $4.4M. The position accounts for ﹤0.01% of the portfolio, ranked #847.

Northwestern Mutual Wealth Management first reported a position in NVO in Q2 2013 and has held it in 51 quarters since. The position peaked at $64M in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Northwestern Mutual Wealth Management held 119,596 shares of Novo Nordisk worth $4.4M as of Q1 2026.
  • Northwestern Mutual Wealth Management sold 54,812 Novo Nordisk shares in Q1 2026, an estimated $2.6M.
  • Novo Nordisk made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #847 holding.
  • Northwestern Mutual Wealth Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 51 quarters since.
  • Northwestern Mutual Wealth Management's Novo Nordisk position peaked at $64M in Q2 2024.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.